In the rapidly evolving landscape of life sciences, Polymerase Chain Reaction (PCR) stands as a foundational molecular biology technique, indispensable…
Read More

In the rapidly evolving landscape of life sciences, Polymerase Chain Reaction (PCR) stands as a foundational molecular biology technique, indispensable…
Read More
Biogen announced on April 20, 2026, a significant strategic acquisition, securing exclusive rights to TJ Biopharma’s novel anti-CD38 immunotherapy, felzartamab,…
Read More
Researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of Medicine have fundamentally challenged the…
Read More
The treatment paradigm for locally advanced head and neck squamous cell carcinoma (LA HNSCC) is undergoing a significant transformation, driven…
Read More
The American Association for Cancer Research (AACR) Annual Meeting, held this year in San Diego, CA, USA, from April 17–22,…
Read More
Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech, granting the Chinese biopharmaceutical company the rights…
Read More
A groundbreaking study led by researchers from the Montefiore Einstein Comprehensive Cancer Center (MECCC) and the Albert Einstein College of…
Read More
Boston, MA – Sai Life Sciences, a leading global contract research, development, and manufacturing organization (CRDMO), recently convened its highly…
Read More
A groundbreaking analysis from LinkedIn’s latest "Skills on the Rise" report has cast a revealing light on the rapidly transforming…
Read More
In an increasingly complex landscape of artificial intelligence tools, Abacus AI has introduced ChatLLM, a platform designed to consolidate diverse…
Read More